21:03:15 EST Wed 04 Mar 2026
Enter Symbol
or Name
USA
CA



Cipher Pharmaceuticals Inc
Symbol CPH
Shares Issued 25,281,181
Close 2026-03-04 C$ 14.86
Market Cap C$ 375,678,350
Recent Sedar+ Documents

Cipher Pharmaceuticals to release 2025 results March 12

2026-03-04 18:02 ET - News Release

Mr. Graham Farrell reports

CIPHER PHARMACEUTICALS SCHEDULES Q4 & FISCAL 2025 EARNINGS RELEASE AND CONFERENCE CALL

Cipher Pharmaceuticals Inc. will release its financial results for the fourth quarter and fiscal 2025 after the market close on Thursday, March 12, 2026. The company will also hold a conference call on Friday, March 13, 2026, at 8:30 a.m. ET to discuss the results and corporate developments.

Conference call details

Date:  Friday, March 13, 2026

Time:  8:30 a.m. ET

Dial-in number:  416-945-7677 or 888-699-1199

Replay:  v

Expires:  March 20, 2026

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the United States and South America.

© 2026 Canjex Publishing Ltd. All rights reserved.